Maha Agenda Faces Backlash Over Pfizer Deal

The ongoing “Make America Healthy” (Maha) initiative led by Robert F. Kennedy Jr. at the Department of Health and Human Services has sparked considerable outrage, particularly regarding a recent agreement with Pfizer, a major player in the pharmaceutical industry. Critics argue that this partnership contradicts the essence of the federal government’s position on big pharma.

On Tuesday, President Trump announced with pride that Pfizer would adhere to his “most advantageous country” executive order. Under this agreement, the company will sell its products in the U.S. at the lowest prices available in other advanced nations, receiving tariff relief in return.

The Trump administration views this deal as a significant achievement in the effort to lower drug prices in the U.S.

“This is a remarkable advantage for Americans,” Kennedy stated from his Oval Office on Tuesday.

As Kennedy continues to promote regulations targeting the pharmaceutical sector, some supporters of the Maha initiative criticized the cooperation between the White House and large drug companies.

Shannon Joy, a self-identified medical freedom advocate, expressed her disapproval in a video released on Thursday. She stated that the Maha movement was about challenging longstanding practices.

“Pfizer’s stock was falling. This might explain their decision to strike a deal with Trump. The company has invested $70 billion in new mRNA technology while also participating in the publicity stunt we witnessed recently,” Joy commented.

A coalition backing the Maha agenda, which includes educators founded by Kennedy and various anti-vaccine groups like Children’s Health Defense, held a demonstration outside Pfizer’s office just days before the announcement.

Kennedy has confronted some of his supporters online, pairing up with Pfizer CEO Albert Bourla.

One of the most widely distributed Covid-19 vaccines produced by Pfizer is now facing scrutiny as critics question its ties with the White House.

James Thorpe, an obstetrician-gynecologist and critic of the Covid-19 vaccine, co-authored a book claiming it caused harm to his pregnant patient and her unborn child. On social media platform X, Thorpe shared a post from FDA Director Marty Makary, who labeled the deal with Pfizer as “the beginning of the end of the Great American Rip-Off.”

“Not Marty, this is the beginning of the end for Maha, as you, Oz, Bobby, and President Trump handed Bourla over to the butcher—Pfizer—for $70 billion,” Thorpe remarked in a response, mentioning Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services.

Others echoed Thorpe’s criticism, suggesting that the Maha initiative is “finished.”

Emerald Robinson, a former Newsmax reporter who departed from the network to share vaccine conspiracy theories during the early days of Covid-19, also condemned the deal on social media.

“Trump has effectively dismantled the Maha coalition. It’s over. What a disgrace,” Robinson wrote.

The Hill reached out to the Department of Health and Human Services regarding inquiries about its agreement with the White House.